The anti-inflammatory markers (IL-10, CCL18, and TGF-β) were upregulated, and the pro-inflammatory markers (TNF-α and IL-6) were downregulated by the macrophages that are differentiated within the tumor matrices. This evidence concerns the gene IL10 and neoplasm.